Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
IDNA
52
HOLDINGS
30%
ALSO IN CANC
CANC
53
HOLDINGS
23%
ALSO IN IDNA
SECTOR DRIFT (IDNA minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 4.4% | 5.9% | 4.4% |
|
ARCELLX, INC. | 5.3% | 3.6% | 3.6% |
|
MERCK & CO. INC. | 4.2% | 3.5% | 3.5% |
|
EXELIXIS INC | 3.4% | 2.2% | 2.2% |
|
IDEAYA BIOSCIENCES, INC. | 3.0% | 2.1% | 2.1% |
IDNA Overweight Relative to CANC
|
MODERNA, INC. | 7.0% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 4.6% |
 |
IPSEN | 4.5% |
 |
BAYER AG | 4.2% |
 |
GSK PLC | 4.1% |
 |
ROCHE HOLDING LTD | 3.8% |
|
VERTEX PHARMACEUTICALS INC | 3.8% |
|
BIONTECH SE SPONSORED ADR | 3.5% |
|
INCYTE CORP | 3.3% |
|
SANOFI-AVENTIS | 3.2% |
IDNA Underweight Relative to CANC
|
NOVARTIS AG | -4.5% |
|
ASTRAZENECA PLC | -4.4% |
|
ELI LILLY & CO | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.0% |
|
BRIDGEBIO PHARMA, INC. | -3.9% |
|
BRISTOL-MYERS SQUIBB CO | -3.6% |
|
IMMUNOME, INC. | -3.2% |
|
NUVALENT, INC. CLASS A | -3.2% |
|
CELCUITY INC. | -3.2% |
|
COGENT BIOSCIENCES INC | -3.0% |